AMBOSS
PrivateLast Round
Early Funding
Mar 25, 2025
Total Funding Raised
$299.3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AMBOSS operates in Healthcare & Life Sciences and is based in Berlin. Its latest recorded funding round was an Early Funding round in March 2025.
AMBOSS is a healthcare education company that provides a digital medical knowledge platform, exam preparation tools, and clinical decision support for medical students and healthcare professionals.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Digital Publishing, NLP & Conversational AI, Blockchain Infrastructure
Business Model
B2C
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AMBOSS Comparables
Compare AMBOSS with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NoveList | 78% | |
| Sanar | 78% | |
| Ascend Learning | 78% |
For institutional investors. Book with your work email.
AMBOSS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 25, 2025 | ||||
| Series B | Sep 30, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AMBOSS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Partech | Early Funding, Series B |
| Partech | Early Funding, Series B |
| LGT Private Banking | Early Funding |
| Target Global | Series B |
| M&G Investments | Early Funding |
| Partech Partners | Series B |
| Holtzbrinck Digital | Series A, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Platform now used by over 1 million medical professionals globally.
- Apr 21, 2026
AI Mode offers structured, evidence-based explanations for medical questions.
For institutional investors. Book with your work email.
AMBOSS Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AMBOSS's valuation, stock price, and market status.
Is AMBOSS a public or private company?
AMBOSS is a private company.
What is the current stock price of AMBOSS?
AMBOSS is a private company, so its shares have no public market price. Caplight tracks AMBOSS's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AMBOSS worth (valuation)?
Valuation information for AMBOSS is not publicly available.
Can I buy AMBOSS stock?
AMBOSS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AMBOSS's last funding round?
AMBOSS's most recent funding round was Early Funding on March 25, 2025.
Who are the main investors in AMBOSS?
Key investors in AMBOSS include Partech, Partech, Target Global, Partech Partners, Lightrock.
Will AMBOSS IPO soon?
No public IPO plans have been announced for AMBOSS.
How can I track AMBOSS secondary market activity?
Caplight tracks bids, offers, and trades in AMBOSS's shares on secondary markets.